T3D Therapeutics: RTP drugmaker raises $15M as it moves forward with potential Alzheimer's treatment
A Triangle company looking to stop Alzheimer's Disease has closed a sizable fundraising round to push forward its pipeline.
Read full article »
T3D Therapeutics is a North Carolina-based biotechnology company that develops novel therapeutics for the treatment of Alzheimers and neurological disorders.
Read more